Pioglitazone enhances mitochondrial biogenesis and ribosomal protein biosynthesis in skeletal muscle in polycystic ovary syndrome.
Insulin resistance is a common metabolic abnormality in women with PCOS and leads to an elevated risk of type 2 diabetes. Studies have shown that thiazolidinediones (TZDs) improve metabolic disturbances in PCOS patients. We hypothesized that the effect of TZDs in PCOS is, in part, mediated by change...
Saved in:
Main Authors: | Vibe Skov, Dorte Glintborg, Steen Knudsen, Qihua Tan, Thomas Jensen, Torben A Kruse, Henning Beck-Nielsen, Kurt Højlund |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2008
|
Subjects: | |
Online Access: | https://doaj.org/article/91a52f2354ba4d80ab0891b2d6f27951 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Genetic alterations within the DENND1A gene in patients with polycystic ovary syndrome (PCOS).
by: Mette B Eriksen, et al.
Published: (2013) -
Metabolomics reveals reduction of metabolic oxidation in women with polycystic ovary syndrome after pioglitazone-flutamide-metformin polytherapy.
by: Maria Vinaixa, et al.
Published: (2011) -
Structural basis of GTPase-mediated mitochondrial ribosome biogenesis and recycling
by: Hauke S. Hillen, et al.
Published: (2021) -
Chemerin regulates autophagy to participate in polycystic ovary syndrome
by: Xiaodong Luo, et al.
Published: (2021) -
Endometrial markers of polycystic ovary syndrome (literature review)
by: E. M. Sharifulin, et al.
Published: (2017)